Valuation: Alembic Limited

Market Cap 22.39B 236M 211M 194M 176M 329M 335M 2.32B 930M 11.78B 885M 866M 37.15B P/E 2025
8.14x
P/E 2026 5.74x
Enterprise Value 21.52B 227M 203M 187M 169M 316M 322M 2.23B 894M 11.32B 850M 832M 35.7B EV / Sales 2025
11.2x
EV / Sales 2026 7.22x
Free-Float
27.23%
Yield 2025
2.44%
Yield 2026 3.38%
1 day-2.52%
1 week+0.40%
1 month-18.71%
3 months-4.41%
6 months-4.50%
Current year-13.71%
1 week 83.75
Extreme 83.75
89.6
1 month 83.75
Extreme 83.75
106.6
Current year 70.64
Extreme 70.64
117.91
1 year 70.64
Extreme 70.64
117.91
3 years 70.64
Extreme 70.64
169
5 years 55.52
Extreme 55.52
169
10 years 25
Extreme 25
169
Manager TitleAgeSince
Chief Executive Officer 46 2025-09-30
Director of Finance/CFO - 2014-08-12
Compliance Officer - 2023-08-31
Director TitleAgeSince
Chairman 78 1967-08-19
Director/Board Member 71 1988-07-01
Director/Board Member 46 2013-04-23
Change 5-day change 1-year change 3-year change Capi.($)
-2.52%+0.40%-12.28%+7.57% 236M
-.--%+1.90%+152.36%+1,090.12% 70.03B
+1.87%+3.22%+15.30%+35.53% 40.22B
+1.35%-1.52%+17.00%+99.53% 29.17B
+4.32%+3.25%+8.55%+3.96% 27.69B
-0.87%+2.15%-19.86%+70.10% 27.38B
+1.18%-0.06%-1.28%+46.07% 27.01B
+0.13%+4.62%+20.08%+18.06% 20.59B
+1.45%-2.02%+27.02%+223.08% 20.05B
+0.90%-2.40%-1.20%+73.20% 19.06B
Average +0.78%+1.01%+20.57%+166.72% 28.15B
Weighted average by Cap. +1.03%+1.34%+43.95%+320.44%

Financials

2025 2026
Net sales 2.22B 23.37M 20.93M 19.25M 17.44M 32.61M 33.22M 230M 92.16M 1.17B 87.7M 85.84M 3.68B 2.4B 25.28M 22.64M 20.82M 18.87M 35.27M 35.93M 248M 99.68M 1.26B 94.86M 92.84M 3.98B
Net income 3.11B 32.72M 29.3M 26.95M 24.42M 45.65M 46.51M 321M 129M 1.63B 123M 120M 5.15B 3.17B 33.43M 29.94M 27.54M 24.95M 46.64M 47.51M 328M 132M 1.67B 125M 123M 5.27B
Net Debt -438M -4.62M -4.13M -3.8M -3.45M -6.44M -6.56M -45.34M -18.2M -231M -17.32M -16.95M -727M -874M -9.2M -8.24M -7.58M -6.87M -12.84M -13.08M -90.43M -36.3M -460M -34.54M -33.81M -1.45B
Projected Income Statement - Annual - Alembic Limited
Logo Alembic Limited
Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical Ingredients Business and the Real Estate Business. The Active Pharmaceutical Ingredients Business is engaged in the manufacturing and marketing of fermentation and chemistry-based active pharmaceutical ingredients (API). The Real Estate Business is engaged in the construction of residential and commercial real estate projects and project management and marketing consultancy. The Company provides certain commercial properties on a lease basis to various tenants. The Company is also engaged in research and development activities in Vadodara. It is also engaged in power generation through co-generation.
Employees
261
Date Price Change Volume
26-10-30 ₹87.20 -2.52% 15,955
26-10-29 ₹89.45 +2.11% 22,754
26-10-28 ₹87.60 +0.40% 25,293
26-10-27 ₹87.25 +2.89% 30,448
26-10-26 ₹84.80 -2.36% 42,636
  1. Stock Market
  2. Stocks
  3. ALEMBICLTD Stock